{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:08:55Z","timestamp":1788433735477,"version":"build-2803163510"},"reference-count":367,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T00:00:00Z","timestamp":1481760000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2016,12,15]]},"DOI":"10.3233\/jhd-160221","type":"journal-article","created":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T00:38:41Z","timestamp":1481935121000},"page":"303-331","source":"Crossref","is-referenced-by-count":47,"title":["Dysregulation of Corticostriatal Connectivity in Huntington\u2019s Disease: A\u00a0Role for Dopamine Modulation"],"prefix":"10.1177","volume":"5","author":[{"given":"Claudia","family":"Rangel-Barajas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George V.","family":"Rebec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"10","key":"10.3233\/JHD-160221_ref1","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/jnnp-2012-304636","article-title":"Prevalence of adult Huntington\u2019s disease in the UK based on diagnoses recorded in general practice records","volume":"84","author":"Evans","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JHD-160221_ref2","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.3233\/JHD-160221_ref3","first-page":"1993","volume-title":"GeneReviews","author":"Warby","year":"1993"},{"issue":"1","key":"10.3233\/JHD-160221_ref4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ncl.2014.09.003","article-title":"Huntington disease: Pathogenesis and treatment","volume":"33","author":"Dayalu","year":"2015","journal-title":"Neurol Clin"},{"key":"10.3233\/JHD-160221_ref5","doi-asserted-by":"crossref","first-page":"c3109","DOI":"10.1136\/bmj.c3109","article-title":"Huntington\u2019s disease","volume":"340","author":"Novak","year":"2010","journal-title":"BMJ"},{"issue":"2","key":"10.3233\/JHD-160221_ref6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JHD-130061","article-title":"Cognitive deficits in transgenic and knock-in HTT mice parallel those in Huntington\u2019s disease","volume":"3","author":"Farrar","year":"2014","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-160221_ref7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3389\/fnbeh.2015.00361","article-title":"Cognitive training at a young age attenuates deficits in the zQ175 mouse model of HD","volume":"9","author":"Curtin","year":"2016","journal-title":"Front Behav Neurosci"},{"issue":"1","key":"10.3233\/JHD-160221_ref8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13311-013-0244-z","article-title":"Treatment of Huntington\u2019s disease","volume":"11","author":"Frank","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.3233\/JHD-160221_ref9","first-page":"209","article-title":"Cognitive changes in Huntington\u2019s disease","volume":"96","author":"Paulsen","year":"2005","journal-title":"Adv Neurol"},{"key":"10.3233\/JHD-160221_ref10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s disease: A clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.3233\/JHD-160221_ref11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-0173(94)00007-C","article-title":"Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop","volume":"20","author":"Parent","year":"1995","journal-title":"Brain Res Brain Res Rev"},{"key":"10.3233\/JHD-160221_ref12","doi-asserted-by":"crossref","unstructured":"Shipp S . The functional logic of corticostriatal connections. Brain Struct Funct. 2016. doi: 10.1007\/s00429-016-1250-9","DOI":"10.1007\/s00429-016-1250-9"},{"key":"10.3233\/JHD-160221_ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-19285-7_1","article-title":"The Neuropathology of Huntington s disease: Classical findings, recent developments and correlation to functional neuroanatomy","volume":"217","author":"R\u00fcb","year":"2015","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"10.3233\/JHD-160221_ref14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.nbd.2016.08.015","article-title":"Symptom heterogeneity in Huntington\u2019s disease correlates with neuronal degeneration in the cerebral cortex","volume":"96","author":"Mehrabi","year":"2016","journal-title":"Neurobiol Dis"},{"issue":"10","key":"10.3233\/JHD-160221_ref15","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1046\/j.0953-816x.2001.01783.x","article-title":"Differential sensitivity of medium- and large-sized striatal neurons to NMDA but not kainate receptor activation in the rat","volume":"14","author":"Cepeda","year":"2001","journal-title":"Eur J Neurosci"},{"issue":"6","key":"10.3233\/JHD-160221_ref16","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jnr.20344","article-title":"Increased GABAergic function in mouse models of Huntington\u2019s disease: Reversal by BDNF","volume":"78","author":"Cepeda","year":"2004","journal-title":"J Neurosci Res"},{"issue":"4","key":"10.3233\/JHD-160221_ref17","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1523\/JNEUROSCI.3539-10.2011","article-title":"Differential electrophysiological changes in striatal output neurons in Huntington\u2019s disease","volume":"31","author":"Andre","year":"2011","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-160221_ref18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","article-title":"Pathophysiology of Huntington\u2019s disease: Time-dependent alterations in synaptic and receptor function","volume":"198","author":"Raymond","year":"2011","journal-title":"Neuroscience"},{"issue":"2","key":"10.3233\/JHD-160221_ref19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.baga.2012.04.029","article-title":"Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington\u2019s disease: Interactions between neurons and astrocytes","volume":"2","author":"Estrada-Sanchez","year":"2012","journal-title":"Basal Ganglia"},{"key":"10.3233\/JHD-160221_ref20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neuroscience.2011.06.075","article-title":"Functional interactions within striatal microcircuit in animal models of Huntington\u2019s disease","volume":"211","author":"Ghiglieri","year":"2012","journal-title":"Neuroscience"},{"issue":"4","key":"10.3233\/JHD-160221_ref21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JHD-130080","article-title":"Striatal synaptosomes from Hdh140Q\/140Q knock-in mice have altered protein levels, novel sites of methionine oxidation, and excess glutamate release after stimulation","volume":"2","author":"Valencia","year":"2013","journal-title":"J Huntingtons Dis"},{"issue":"7","key":"10.3233\/JHD-160221_ref22","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1152\/jn.01056.2014","article-title":"Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington\u2019s disease","volume":"113","author":"Indersmitten","year":"2015","journal-title":"J Neurophysiol"},{"issue":"5","key":"10.3233\/JHD-160221_ref23","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1096\/fj.12-219220","article-title":"A novel human embryonic stem cell-derived Huntington\u2019s disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration","volume":"27","author":"Lu","year":"2013","journal-title":"FASEB J"},{"issue":"2","key":"10.3233\/JHD-160221_ref24","doi-asserted-by":"crossref","first-page":"e88284","DOI":"10.1371\/journal.pone.0088284","article-title":"Phosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity","volume":"9","author":"Watkin","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.3233\/JHD-160221_ref25","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s12035-014-8932-1","article-title":"Polyglutamine aggregation in Huntington Disease: Does structure determine toxicity?","volume":"52","author":"Hoffner","year":"2015","journal-title":"Mol Neurobiol"},{"issue":"4","key":"10.3233\/JHD-160221_ref26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease","volume":"4","author":"Andrew","year":"1993","journal-title":"Nat Genet"},{"issue":"3","key":"10.3233\/JHD-160221_ref27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ajhg.2012.01.005","article-title":"Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region","volume":"90","author":"Lee","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.3233\/JHD-160221_ref28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-2000-7461","article-title":"Huntington disease in children: Genotype-phenotype correlation","volume":"31","author":"Rasmussen","year":"2000","journal-title":"Neuropediatrics"},{"issue":"2","key":"10.3233\/JHD-160221_ref29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-2002-32367","article-title":"Chorea Huntington: A rare case with childhood onset","volume":"33","author":"Gencik","year":"2002","journal-title":"Neuropediatrics"},{"issue":"6","key":"10.3233\/JHD-160221_ref30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"issue":"8","key":"10.3233\/JHD-160221_ref31","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","volume":"8","author":"van der Burg","year":"2009","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.3233\/JHD-160221_ref32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0092-8674(02)00962-5","article-title":"Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor","volume":"111","author":"Lee","year":"2002","journal-title":"Cell"},{"issue":"5334","key":"10.3233\/JHD-160221_ref33","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"issue":"17","key":"10.3233\/JHD-160221_ref34","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s00018-005-5084-5","article-title":"Synaptic dysfunction in Huntington\u2019s disease: A new perspective","volume":"62","author":"Smith","year":"2005","journal-title":"Cell Mol Life Sci"},{"issue":"17","key":"10.3233\/JHD-160221_ref35","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1093\/hmg\/ddu166","article-title":"Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington\u2019s disease","volume":"23","author":"Smith","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.3233\/JHD-160221_ref36","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1523\/JNEUROSCI.2812-14.2015","article-title":"Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington\u2019s disease","volume":"35","author":"Estrada-Sanchez","year":"2015","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-160221_ref37","doi-asserted-by":"crossref","first-page":"31022","DOI":"10.1038\/srep31022","article-title":"Inhibition of DNA methyltransferases blocks mutant huntingtin-induced neurotoxicity","volume":"6","author":"Pan","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"10.3233\/JHD-160221_ref38","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","article-title":"Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington\u2019s disease","volume":"23","author":"Cepeda","year":"2003","journal-title":"J Neurosci"},{"issue":"11","key":"10.3233\/JHD-160221_ref39","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2004.08.008","article-title":"Genetic mouse models of Huntington\u2019s and Parkinson\u2019s diseases: Illuminating but imperfect","volume":"27","author":"Levine","year":"2004","journal-title":"Trends Neurosci"},{"issue":"5-6","key":"10.3233\/JHD-160221_ref40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington\u2019s disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog Neurobiol"},{"issue":"3","key":"10.3233\/JHD-160221_ref41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"issue":"3","key":"10.3233\/JHD-160221_ref42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.3233\/JHD-160221_ref43","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbadis.2009.04.001","article-title":"Mouse models of Huntington\u2019s disease and methodological considerations for therapeutic trials","volume":"1792","author":"Ferrante","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.3233\/JHD-160221_ref44","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/mt.2016.12","article-title":"Human mesenchymal stem cells genetically engineered to overexpress brain-derived neurotrophic factor improve outcomes in Huntington\u2019s disease mouse models","volume":"24","author":"Pollock","year":"2016","journal-title":"Mol Ther"},{"issue":"6","key":"10.3233\/JHD-160221_ref45","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/hmg\/ddg075","article-title":"Transgenic rat model of Huntington\u2019s disease","volume":"12","author":"von H\u00f6rsten","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.3233\/JHD-160221_ref46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbr.2006.02.028","article-title":"Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington\u2019s disease transgenic ratmodel","volume":"170","author":"Cao","year":"2006","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.3233\/JHD-160221_ref47","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1037\/a0028028","article-title":"Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington\u2019s disease","volume":"126","author":"Fink","year":"2012","journal-title":"Behav Neurosci"},{"issue":"1","key":"10.3233\/JHD-160221_ref48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"issue":"13","key":"10.3233\/JHD-160221_ref49","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"24","key":"10.3233\/JHD-160221_ref50","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J Neurosci"},{"issue":"3","key":"10.3233\/JHD-160221_ref51","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.neuroscience.2008.09.020","article-title":"Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington\u2019s disease","volume":"157","author":"Spampanato","year":"2008","journal-title":"Neuroscience"},{"issue":"1","key":"10.3233\/JHD-160221_ref52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats","volume":"465","author":"Menalled","year":"2003","journal-title":"J Comp Neurol"},{"issue":"3","key":"10.3233\/JHD-160221_ref53","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1602\/neurorx.2.3.465","article-title":"Knock-in mouse models of Huntington\u2019s disease","volume":"2","author":"Menalled","year":"2005","journal-title":"NeuroRx"},{"issue":"12","key":"10.3233\/JHD-160221_ref54","doi-asserted-by":"crossref","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.3233\/JHD-160221_ref55","doi-asserted-by":"crossref","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","article-title":"Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease","volume":"7","author":"Heikkinen","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.3233\/JHD-160221_ref56","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1152\/jn.90606.2008","article-title":"Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington\u2019s disease","volume":"100","author":"Miller","year":"2008","journal-title":"J Neurophysiol"},{"issue":"36","key":"10.3233\/JHD-160221_ref57","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1523\/JNEUROSCI.2804-08.2008","article-title":"Altered information processing in the prefrontal cortex of Huntington\u2019s disease mouse models","volume":"28","author":"Walker","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-160221_ref58","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuroscience.2015.10.039","article-title":"Pathological gamma oscillations, impaired dopamine release, synapse loss and reduced dynamic range of unitary glutamatergic synaptic transmission in the striatum of hypokinetic Q175 Huntington mice","volume":"311","author":"Rothe","year":"2015","journal-title":"Neuroscience"},{"key":"10.3233\/JHD-160221_ref59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.ne.06.030183.000445","article-title":"Speculations on the functional anatomy of basal ganglia disorders","volume":"6","author":"Penney","year":"1983","journal-title":"Annu Rev Neurosci"},{"issue":"10","key":"10.3233\/JHD-160221_ref60","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci"},{"issue":"7","key":"10.3233\/JHD-160221_ref61","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0166-2236(90)90107-L","article-title":"Functional architecture of basal ganglia circuits: Neural substrates of parallel processing","volume":"13","author":"Alexander","year":"1990","journal-title":"Trends Neurosci"},{"issue":"4986","key":"10.3233\/JHD-160221_ref62","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"issue":"12","key":"10.3233\/JHD-160221_ref63","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1523\/JNEUROSCI.22-12-05042.2002","article-title":"D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1\/2\/MAP kinase","volume":"22","author":"Gerfen","year":"2002","journal-title":"J Neurosci"},{"issue":"3","key":"10.3233\/JHD-160221_ref64","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nn.3632","article-title":"Basal ganglia subcircuits distinctively encode the parsing and concatenation of action sequences","volume":"17","author":"Jin","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.3233\/JHD-160221_ref65","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1038\/ncomms5315","article-title":"Balanced activity in basal ganglia projection pathways is critical for contraversive movements","volume":"5","author":"Tecuapetla","year":"2014","journal-title":"Nat Commun"},{"issue":"3","key":"10.3233\/JHD-160221_ref66","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2016.06.032","article-title":"Complementary contributions of striatal projection pathways to action initiation and execution","volume":"166","author":"Tecuapetla","year":"2016","journal-title":"Cell"},{"issue":"47","key":"10.3233\/JHD-160221_ref67","doi-asserted-by":"crossref","first-page":"18531","DOI":"10.1523\/JNEUROSCI.1278-13.2013","article-title":"Control of basal ganglia output by direct and indirect pathway projection neurons","volume":"33","author":"Freeze","year":"2013","journal-title":"J Neurosci"},{"issue":"6","key":"10.3233\/JHD-160221_ref68","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/ana.410380605","article-title":"Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington\u2019s disease patients","volume":"38","author":"Richfield","year":"1995","journal-title":"Ann Neurol"},{"issue":"2","key":"10.3233\/JHD-160221_ref69","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0306-4522(94)00427-7","article-title":"Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington\u2019s disease using high resolution image analysis","volume":"64","author":"Sapp","year":"1995","journal-title":"Neuroscience"},{"issue":"4","key":"10.3233\/JHD-160221_ref70","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410310412","article-title":"Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington\u2019s disease","volume":"31","author":"Albin","year":"1992","journal-title":"Ann Neurol"},{"issue":"38","key":"10.3233\/JHD-160221_ref71","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1523\/JNEUROSCI.1990-04.2004","article-title":"Evidence for differential cortical input to direct pathway versus indirect pathway striatal projection neurons in rats","volume":"24","author":"Lei","year":"2004","journal-title":"J Neurosci"},{"issue":"3","key":"10.3233\/JHD-160221_ref72","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jchemneu.2004.02.005","article-title":"Differential loss of striatal projection systems in Huntington\u2019s disease: A quantitative immunohistochemical study","volume":"27","author":"Deng","year":"2004","journal-title":"J Chem Neuroanat"},{"key":"10.3233\/JHD-160221_ref73","unstructured":"Barry J , Cepeda C , Levine MS . Direct and Indirect striatal output pathways differentially affect their targets in mouse models of Huntongton\u2019s disease. Poster Presentation. Hereditary Disease Foundation (HD2016). \u201cThe Milton Wexler Celebration of Life\u201d. August 3-6, 2016. Cambridge, MA."},{"issue":"2","key":"10.3233\/JHD-160221_ref74","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0006-8993(95)01333-4","article-title":"Corticostriatal projections from layer V cells in rat are collaterals of long-range corticofugal axons","volume":"709","author":"Levesque","year":"1996","journal-title":"Brain Res"},{"issue":"7","key":"10.3233\/JHD-160221_ref75","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/cercor\/8.7.602","article-title":"Axonal arborization of corticostriatal and corticothalamic fibers arising from prelimbic cortex in the rat","volume":"8","author":"Levesque","year":"1998","journal-title":"Cereb Cortex"},{"issue":"3","key":"10.3233\/JHD-160221_ref76","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1385\/MN:28:3:259","article-title":"Wild-type huntingtin plays a role in brain development and neuronal survival","volume":"28","author":"Reiner","year":"2003","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JHD-160221_ref77","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fnana.2010.00142","article-title":"Corticostriatal projection neurons - dichotomous types and dichotomous functions","volume":"4","author":"Reiner","year":"2010","journal-title":"Front Neuroanat"},{"issue":"4","key":"10.3233\/JHD-160221_ref78","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrn3469","article-title":"Corticostriatal connectivity and its role in disease","volume":"14","author":"Shepherd","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JHD-160221_ref79","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/B978-0-12-374767-9.00018-4","volume-title":"Handbook of Basal Ganglia Structure and Function","author":"Reiner","year":"2010"},{"issue":"21","key":"10.3233\/JHD-160221_ref80","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.1523\/JNEUROSCI.23-21-07844.2003","article-title":"Activity of different classes of neurons of the motor cortex during postural corrections","volume":"23","author":"Beloozerova","year":"2003","journal-title":"J\u00a0Neurosci"},{"issue":"10","key":"10.3233\/JHD-160221_ref81","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/jamaneurol.2014.1272","article-title":"Effect of advancing age on outcomes of deep brain stimulation for Parkinson disease","volume":"71","author":"DeLong","year":"2014","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.3233\/JHD-160221_ref82","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/hipo.450030404","article-title":"Perforated axospinous synapses with multiple, completely partitioned transmission zones: Probable structural intermediates in synaptic plasticity","volume":"3","author":"Geinisman","year":"1993","journal-title":"Hippocampus"},{"issue":"2-3","key":"10.3233\/JHD-160221_ref83","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1515\/REVNEURO.2000.11.2-3.159","article-title":"Regulation of quantal size by presynaptic mechanisms","volume":"11","author":"Sulzer","year":"2000","journal-title":"Rev Neurosci"},{"issue":"15","key":"10.3233\/JHD-160221_ref84","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.3233\/JHD-160221_ref85","doi-asserted-by":"crossref","first-page":"e47026","DOI":"10.1371\/journal.pone.0047026","article-title":"Dysfunctional behavioral modulation of corticostriatal communication in the R6\/2 mouse model of Huntington\u2019s disease","volume":"7","author":"Hong","year":"2012","journal-title":"PLoS One"},{"key":"10.3233\/JHD-160221_ref86","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fnsys.2011.00026","article-title":"Dysregulated neuronal activity patterns implicate corticostriatal circuit dysfunction in multiple rodent models of Huntington\u2019s disease","volume":"5","author":"Miller","year":"2011","journal-title":"Front Syst Neurosci"},{"issue":"7","key":"10.3233\/JHD-160221_ref87","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0166-2236(90)90111-M","article-title":"Excitotoxic injury of the neostriatum: A model for Huntington\u2019s disease","volume":"13","author":"DiFiglia","year":"1990","journal-title":"Trends Neurosci"},{"issue":"6","key":"10.3233\/JHD-160221_ref88","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","article-title":"Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington\u2019s disease transgenic mice","volume":"86","author":"Klapstein","year":"2001","journal-title":"J Neurophysiol"},{"issue":"10","key":"10.3233\/JHD-160221_ref89","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.0953-816X.2004.03374.x","article-title":"Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6\/1 Huntington\u2019s disease transgenic mice","volume":"19","author":"Spires","year":"2004","journal-title":"Eur J Neurosci"},{"issue":"17","key":"10.3233\/JHD-160221_ref90","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1093\/hmg\/ddv224","article-title":"Decreased glycogen synthase kinase-3 levels and activity contribute to Huntington\u2019s disease","volume":"24","author":"Fernandez-Nogales","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.3233\/JHD-160221_ref91","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/brain\/103.1.179","article-title":"Neurochemical alterations in Huntington\u2019s chorea: A study of post-mortem brain tissue","volume":"103","author":"Spokes","year":"1980","journal-title":"Brain"},{"issue":"3","key":"10.3233\/JHD-160221_ref92","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","article-title":"Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice","volume":"46","author":"Gu","year":"2005","journal-title":"Neuron"},{"issue":"4","key":"10.3233\/JHD-160221_ref93","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1152\/jn.01118.2005","article-title":"Altered cortical glutamate receptor function in the R6\/2 model of Huntington\u2019s disease","volume":"95","author":"Andre","year":"2006","journal-title":"J Neurophysiol"},{"issue":"5","key":"10.3233\/JHD-160221_ref94","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nm.3514","article-title":"Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington\u2019s disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med"},{"issue":"1","key":"10.3233\/JHD-160221_ref95","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0306-4522(01)00038-0","article-title":"GABA promotes survival but not proliferation of parvalbumin-immunoreactive interneurons in rodent neostriatum: An in vivo study with stereology","volume":"104","author":"Luk","year":"2001","journal-title":"Neuroscience"},{"issue":"11","key":"10.3233\/JHD-160221_ref96","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.tins.2004.08.007","article-title":"GABAergic microcircuits in the neostriatum","volume":"27","author":"Tepper","year":"2004","journal-title":"Trends Neurosci"},{"issue":"11","key":"10.3233\/JHD-160221_ref97","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1523\/JNEUROSCI.13-11-04908.1993","article-title":"Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum","volume":"13","author":"Kawaguchi","year":"1993","journal-title":"J Neurosci"},{"issue":"12","key":"10.3233\/JHD-160221_ref98","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0166-2236(95)98374-8","article-title":"Striatal interneurones: Chemical, physiological and morphological characterization","volume":"18","author":"Kawaguchi","year":"1995","journal-title":"Trends Neurosci"},{"issue":"3","key":"10.3233\/JHD-160221_ref99","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0306-4522(92)90293-B","article-title":"Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat","volume":"51","author":"Lapper","year":"1992","journal-title":"Neuroscience"},{"issue":"9","key":"10.3233\/JHD-160221_ref100","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tins.2004.07.004","article-title":"The thalamostriatal system: A highly specific network of the basal ganglia circuitry","volume":"27","author":"Smith","year":"2004","journal-title":"Trends Neurosci"},{"issue":"2","key":"10.3233\/JHD-160221_ref101","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuron.2010.06.017","article-title":"Thalamic gating of corticostriatal signaling by cholinergic interneurons","volume":"67","author":"Ding","year":"2010","journal-title":"Neuron"},{"issue":"25","key":"10.3233\/JHD-160221_ref102","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1523\/JNEUROSCI.0435-08.2008","article-title":"Corticostriatal and thalamostriatal synapses have distinctive properties","volume":"28","author":"Ding","year":"2008","journal-title":"J\u00a0Neurosci"},{"key":"10.3233\/JHD-160221_ref103","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.nbd.2015.11.020","article-title":"Differential changes in thalamic and cortical excitatory synapses onto striatal spiny projection neurons in a Huntington disease mouse model","volume":"86","author":"Kolodziejczyk","year":"2016","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JHD-160221_ref104","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2013.08.009","article-title":"Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington\u2019s disease mice","volume":"60","author":"Deng","year":"2013","journal-title":"Neurobiol Dis"},{"issue":"4","key":"10.3233\/JHD-160221_ref105","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.neuron.2015.12.038","article-title":"Pathway-specific remodeling of thalamostriatal synapses in parkinsonian mice","volume":"89","author":"Parker","year":"2016","journal-title":"Neuron"},{"key":"10.3233\/JHD-160221_ref106","first-page":"27","volume-title":"Basal Ganglia and Behavior: Sensory Aspects of Motor Functioning","author":"West","year":"1987"},{"issue":"2","key":"10.3233\/JHD-160221_ref107","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0006-8993(88)90399-X","article-title":"Heterogeneous responses of neostriatal neurons to amphetamine in freely moving rats","volume":"463","author":"Gardiner","year":"1988","journal-title":"Brain Res"},{"issue":"1","key":"10.3233\/JHD-160221_ref108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0149-7634(05)80226-X","article-title":"Striatal single-unit responses to amphetamine and neuroleptics in freely moving rats","volume":"17","author":"Haracz","year":"1993","journal-title":"Neurosci Biobehav Rev"},{"issue":"1-2","key":"10.3233\/JHD-160221_ref109","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0006-8993(98)00905-6","article-title":"Cocaine-induced activation of striatal neurons during focused stereotypy in rats","volume":"810","author":"White","year":"1998","journal-title":"Brain Res"},{"issue":"1","key":"10.3233\/JHD-160221_ref110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0006-8993(93)90751-8","article-title":"Neuronal and behavioral correlates of intrastriatal infusions of amphetamine in freely moving rats","volume":"627","author":"Wang","year":"1993","journal-title":"Brain Res"},{"issue":"4","key":"10.3233\/JHD-160221_ref111","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F","article-title":"Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington\u2019s disease","volume":"58","author":"Levine","year":"1999","journal-title":"J Neurosci Res"},{"issue":"1","key":"10.3233\/JHD-160221_ref112","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neuroscience.2005.08.062","article-title":"Hyperactive striatal neurons in symptomatic Huntington R6\/2 mice: Variations with behavioral state and repeated ascorbate treatment","volume":"137","author":"Rebec","year":"2006","journal-title":"Neuroscience"},{"issue":"12","key":"10.3233\/JHD-160221_ref113","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1073\/pnas.120166397","article-title":"Severe deficiencies in dopamine signaling in presymptomatic Huntington\u2019s disease mice","volume":"97","author":"Bibb","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2-3","key":"10.3233\/JHD-160221_ref114","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000017308","article-title":"Postnatal development of the rat neostriatum: Electrophysiological, light- and electron-microscopic studies","volume":"20","author":"Tepper","year":"1998","journal-title":"Dev Neurosci"},{"issue":"5","key":"10.3233\/JHD-160221_ref115","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/8138","article-title":"Inhibitory control of neostriatal projection neurons by GABAergic interneurons","volume":"2","author":"Koos","year":"1999","journal-title":"Nat Neurosci"},{"issue":"10","key":"10.3233\/JHD-160221_ref116","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J Neurosci"},{"issue":"12","key":"10.3233\/JHD-160221_ref117","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/mds.25624","article-title":"Striatal parvalbuminergic neurons are lost in Huntington\u2019s disease: Implications for dystonia","volume":"28","author":"Reiner","year":"2013","journal-title":"Mov Disord"},{"issue":"17","key":"10.3233\/JHD-160221_ref118","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.1523\/JNEUROSCI.17-17-06761.1997","article-title":"Dopaminergic neurons intrinsic to the primate striatum","volume":"17","author":"Betarbet","year":"1997","journal-title":"J Neurosci"},{"issue":"20","key":"10.3233\/JHD-160221_ref119","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.1523\/JNEUROSCI.5996-09.2010","article-title":"Electrophysiological and morphological characteristics and synaptic connectivity of tyrosine hydroxylase-expressing neurons in adult mouse striatum","volume":"30","author":"Ibanez-Sandoval","year":"2010","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-160221_ref120","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fnana.2010.00150","article-title":"Heterogeneity and diversity of striatal GABAergic interneurons","volume":"4","author":"Tepper","year":"2010","journal-title":"Front Neuroanat"},{"issue":"24","key":"10.3233\/JHD-160221_ref121","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1073\/pnas.82.24.8780","article-title":"The neostriatal mosaic: Compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey","volume":"82","author":"Gerfen","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"10.3233\/JHD-160221_ref122","doi-asserted-by":"crossref","first-page":"8158","DOI":"10.1523\/JNEUROSCI.22-18-08158.2002","article-title":"Synaptic convergence of motor and somatosensory cortical afferents onto GABAergic interneurons in the rat striatum","volume":"22","author":"Ramanathan","year":"2002","journal-title":"J Neurosci"},{"issue":"1-2","key":"10.3233\/JHD-160221_ref123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(90)90002-S","article-title":"Parvalbumin-immunoreactive neurons in the rat neostriatum: A light and electron microscopic study","volume":"17","author":"Kita","year":"1990","journal-title":"Brain Res"},{"issue":"4","key":"10.3233\/JHD-160221_ref124","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1523\/JNEUROSCI.4418-08.2009","article-title":"Network architecture of gap junction-coupled neuronal linkage in the striatum","volume":"29","author":"Fukuda","year":"2009","journal-title":"J Neurosci"},{"issue":"36","key":"10.3233\/JHD-160221_ref125","doi-asserted-by":"crossref","first-page":"7916","DOI":"10.1523\/JNEUROSCI.2163-04.2004","article-title":"Comparison of IPSCs evoked by spiny and fast-spiking neurons in the neostriatum","volume":"24","author":"Koos","year":"2004","journal-title":"J Neurosci"},{"issue":"2","key":"10.3233\/JHD-160221_ref126","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1152\/jn.00802.2005","article-title":"A comparative voltage and current-clamp analysis of feedback and feedforward synaptic transmission in the striatal microcircuit in vitro","volume":"95","author":"Gustafson","year":"2006","journal-title":"J Neurophysiol"},{"issue":"1","key":"10.3233\/JHD-160221_ref127","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1523\/JNEUROSCI.18-01-00266.1998","article-title":"Up and down states in striatal medium spiny neurons simultaneously recorded with spontaneous activity in fast-spiking interneurons studied in cortex-striatum-substantia nigra organotypic cultures","volume":"18","author":"Plenz","year":"1998","journal-title":"J Neurosci"},{"issue":"Pt 1","key":"10.3233\/JHD-160221_ref128","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1113\/jphysiol.2003.040857","article-title":"Voltage-dependent membrane potential oscillations of rat striatal fast-spiking interneurons","volume":"549","author":"Bracci","year":"2003","journal-title":"J Physiol"},{"issue":"6","key":"10.3233\/JHD-160221_ref129","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neuron.2004.08.035","article-title":"Oscillatory entrainment of striatal neurons in freely moving rats","volume":"43","author":"Berke","year":"2004","journal-title":"Neuron"},{"issue":"4","key":"10.3233\/JHD-160221_ref130","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0896-6273(04)00043-1","article-title":"Electrical coupling and neuronal synchronization in the Mammalian brain","volume":"41","author":"Bennett","year":"2004","journal-title":"Neuron"},{"issue":"4","key":"10.3233\/JHD-160221_ref131","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/(SICI)1098-2396(19990915)33:4<259::AID-SYN2>3.0.CO;2-X","article-title":"Subconvulsive dose of pentylenetetrazole increases the firing rate of substantia nigra pars reticulata neurons in dystonic but not in nondystonic hamsters","volume":"33","author":"Gernert","year":"1999","journal-title":"Synapse"},{"issue":"18","key":"10.3233\/JHD-160221_ref132","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1523\/JNEUROSCI.20-18-07052.2000","article-title":"Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia","volume":"20","author":"Gernert","year":"2000","journal-title":"J Neurosci"},{"issue":"16","key":"10.3233\/JHD-160221_ref133","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.1523\/JNEUROSCI.0195-15.2015","article-title":"Are striatal tyrosine hydroxylase interneurons dopaminergic?","volume":"35","author":"Xenias","year":"2015","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-160221_ref134","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.neuropharm.2015.03.036","article-title":"Dopaminergic and cholinergic modulation of striatal tyrosine hydroxylase interneurons","volume":"95","author":"Ibanez-Sandoval","year":"2015","journal-title":"Neuropharmacology"},{"issue":"Pt 1","key":"10.3233\/JHD-160221_ref135","first-page":"222","article-title":"The fate of striatal dopaminergic neurons in Parkinson\u2019s disease and Huntington\u2019s chorea","volume":"130","author":"Huot","year":"2007","journal-title":"Brain"},{"issue":"6","key":"10.3233\/JHD-160221_ref136","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1523\/JNEUROSCI.14-06-03969.1994","article-title":"Responses of tonically active neurons in the primate\u2019s striatum undergo systematic changes during behavioral sensorimotor conditioning","volume":"14","author":"Aosaki","year":"1994","journal-title":"J Neurosci"},{"issue":"15","key":"10.3233\/JHD-160221_ref137","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1073\/pnas.81.15.4998","article-title":"Tonically discharging putamen neurons exhibit set-dependent responses","volume":"81","author":"Kimura","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.3233\/JHD-160221_ref138","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1152\/jn.00853.2004","article-title":"Cholinergic control of firing pattern and neurotransmission in rat neostriatal projection neurons: Role of CaV2.1 and CaV2.2 Ca2+ channels","volume":"93","author":"Perez-Rosello","year":"2005","journal-title":"J Neurophysiol"},{"issue":"10","key":"10.3233\/JHD-160221_ref139","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tins.2007.07.008","article-title":"Re-emergence of striatal cholinergic interneurons in movement disorders","volume":"30","author":"Pisani","year":"2007","journal-title":"Trends Neurosci"},{"issue":"4","key":"10.3233\/JHD-160221_ref140","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/syn.1089","article-title":"Vesicular neurotransmitter transporters in Huntington\u2019s disease: Initial observations and comparison with traditional synaptic markers","volume":"41","author":"Suzuki","year":"2001","journal-title":"Synapse"},{"issue":"21","key":"10.3233\/JHD-160221_ref141","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1093\/hmg\/ddl252","article-title":"Cholinergic neuronal defect without cell loss in Huntington\u2019s disease","volume":"15","author":"Smith","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.3233\/JHD-160221_ref142","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1046\/j.1468-1331.2002.00447_4.x","article-title":"Rivastigmine in the treatment of Huntington\u2019s disease","volume":"9","author":"Rot","year":"2002","journal-title":"Eur J Neurol"},{"issue":"17","key":"10.3233\/JHD-160221_ref143","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1002\/cne.24013","article-title":"Cholinergic interneurons in the Q140 knock-in mouse model of Huntington\u2019s disease: Reductions in dendritic branching and thalamostriatal input","volume":"524","author":"Deng","year":"2016","journal-title":"J\u00a0Comp Neurol"},{"issue":"1-2","key":"10.3233\/JHD-160221_ref144","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1155\/NP.2003.107","article-title":"The basal ganglia and motor control","volume":"10","author":"Groenewegen","year":"2003","journal-title":"Neural Plast"},{"issue":"3","key":"10.3233\/JHD-160221_ref145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/1467-9450.00238","article-title":"Dopamine and cognitive functioning: Brain imaging findings in Huntington\u2019s disease and normal aging","volume":"42","author":"Backman","year":"2001","journal-title":"Scand J Psychol"},{"key":"10.3233\/JHD-160221_ref146","first-page":"1","article-title":"Differential contributions of ventral and dorsal striatum to early and late phases of cognitive set reconfiguration","volume":"15","author":"Sleezer","year":"2016","journal-title":"J Cogn Neurosci"},{"issue":"3","key":"10.3233\/JHD-160221_ref147","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1113\/jphysiol.2007.130864","article-title":"Dopamine D1 receptor activation regulates sodium channel-dependent EPSP amplification in rat prefrontal cortex pyramidal neurons","volume":"581","author":"Rotaru","year":"2007","journal-title":"J Physiol"},{"issue":"Pt A","key":"10.3233\/JHD-160221_ref148","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neuropharm.2016.07.024","article-title":"PPARalpha modulation of mesolimbic dopamine transmission rescues depression-related behaviors","volume":"110","author":"Scheggi","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.3233\/JHD-160221_ref149","doi-asserted-by":"crossref","unstructured":"Maia TV , Frank MJ . An integrative perspective on the role of dopamine in schizophrenia. Biol Psychiatry. 2016; doi: 10.1016\/j.biopsych.2016.05.021","DOI":"10.1016\/j.biopsych.2016.05.021"},{"issue":"9","key":"10.3233\/JHD-160221_ref150","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1523\/JNEUROSCI.19-09-03594.1999","article-title":"Striatal neuronal activity and responsiveness to dopamine and glutamate after selective blockade of D1 and D2 dopamine receptors in freely moving rats","volume":"19","author":"Kiyatkin","year":"1999","journal-title":"J Neurosci"},{"issue":"1","key":"10.3233\/JHD-160221_ref151","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ana.410260103","article-title":"A quantitative investigation of the substantia nigra in Huntington\u2019s disease","volume":"26","author":"Oyanagi","year":"1989","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"10.3233\/JHD-160221_ref152","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000116721","article-title":"Neuropathology of the substantia nigra","volume":"31","author":"Gibb","year":"1991","journal-title":"Eur Neurol"},{"issue":"8","key":"10.3233\/JHD-160221_ref153","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.parkreldis.2011.05.012","article-title":"Serotonin and dopamine striatal innervation in Parkinson\u2019s disease and Huntington\u2019s chorea","volume":"17","author":"Bedard","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.3233\/JHD-160221_ref154","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molbrainres.2003.08.009","article-title":"Analysis of cellular, transgenic and human models of Huntington\u2019s disease reveals tyrosine hydroxylase alterations and substantia nigra neuropathology","volume":"119","author":"Yohrling","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"issue":"Pt 3","key":"10.3233\/JHD-160221_ref155","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/120.3.503","article-title":"PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington\u2019s disease","volume":"120","author":"Ginovart","year":"1997","journal-title":"Brain"},{"issue":"9","key":"10.3233\/JHD-160221_ref156","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1212\/WNL.54.9.1753","article-title":"Decreased striatal monoaminergic terminals in Huntington disease","volume":"54","author":"Bohnen","year":"2009","journal-title":"Neurology"},{"issue":"9","key":"10.3233\/JHD-160221_ref157","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.parkreldis.2013.05.005","article-title":"Nigral involvement and nigrostriatal dysfunction in Huntington\u2019s disease: Evidences from an MRI and SPECT study","volume":"19","author":"Kiferle","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.3233\/JHD-160221_ref158","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/nbdi.2002.0534","article-title":"Evidence for dysfunction of the nigrostriatal pathway in the R6\/1 line of transgenic Huntington\u2019s disease mice","volume":"11","author":"Petersen","year":"2002","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.3233\/JHD-160221_ref159","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000375126","article-title":"Dysfunctional dopaminergic neurones in mouse models of Huntington\u2019s disease: A role for SK3 channels","volume":"15","author":"Dallerac","year":"2015","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JHD-160221_ref160","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainres.2012.02.042","article-title":"Motor function and dopamine release measurements in transgenic Huntington\u2019s disease model rats","volume":"1450","author":"Ortiz","year":"2012","journal-title":"Brain Res"},{"issue":"3","key":"10.3233\/JHD-160221_ref161","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1471-4159.2006.03762.x","article-title":"Dopamine release is severely compromised in the R6\/2 mouse model of Huntington\u2019s disease","volume":"97","author":"Johnson","year":"2006","journal-title":"J Neurochem"},{"issue":"4","key":"10.3233\/JHD-160221_ref162","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3233\/JHD-140129","article-title":"Comparison of phosphodiesterase 10A, dopamine receptors D1 and D2 and dopamine transporter ligand binding in the striatum of the R6\/2 and BACHD mouse models of Huntington\u2019s disease","volume":"3","author":"Miller","year":"2014","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-160221_ref163","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fnsys.2011.00061","article-title":"In vivo dopamine efflux is decreased in striatum of both fragment (R6\/2) and full-length (YAC128) transgenic mouse models of Huntington\u2019s disease","volume":"5","author":"Callahan","year":"2011","journal-title":"Front Syst Neurosci"},{"issue":"18","key":"10.3233\/JHD-160221_ref164","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1523\/JNEUROSCI.0135-16.2016","article-title":"Compromised dopaminergic encoding of reward accompanying suppressed willingness to overcome high effort costs is a prominent prodromal characteristic of the Q175 mouse model of Huntington\u2019s disease","volume":"36","author":"Covey","year":"2016","journal-title":"J Neurosci"},{"issue":"3","key":"10.3233\/JHD-160221_ref165","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ana.410220318","article-title":"Elevated serotonin and reduced dopamine in subregionally divided Huntington\u2019s disease striatum","volume":"22","author":"Kish","year":"1987","journal-title":"Ann Neurol"},{"issue":"3","key":"10.3233\/JHD-160221_ref166","doi-asserted-by":"crossref","first-page":"e18336","DOI":"10.1371\/journal.pone.0018336","article-title":"Altered dopamine and serotonin metabolism in motorically asymptomatic R6\/2 mice","volume":"6","author":"Mochel","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.3233\/JHD-160221_ref167","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0896-6273(00)80798-9","article-title":"Beyond the dopamine receptor: The DARPP-32\/protein phosphatase-1 cascade","volume":"23","author":"Greengard","year":"1999","journal-title":"Neuron"},{"issue":"4169","key":"10.3233\/JHD-160221_ref168","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1126\/science.186.4169.1118","article-title":"Adenosine 3\u2019,5\u2019-monophosphate content in rat caudate nucleus: Demonstration of dopaminergic and adrenergic receptors","volume":"186","author":"Forn","year":"1974","journal-title":"Science"},{"issue":"1","key":"10.3233\/JHD-160221_ref169","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0015-0282(16)46764-6","article-title":"Effect of prostaglandin D2 on gonadotropin release from rat anterior pituitary in vitro","volume":"39","author":"Arisawa","year":"1983","journal-title":"Fertil Steril"},{"issue":"1","key":"10.3233\/JHD-160221_ref170","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: From structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol Rev"},{"issue":"5","key":"10.3233\/JHD-160221_ref171","doi-asserted-by":"crossref","first-page":"349","DOI":"10.14336\/AD.2015.0330","article-title":"Dopamine receptors and neurodegeneration","volume":"6","author":"Rangel-Barajas","year":"2015","journal-title":"Aging Dis"},{"key":"10.3233\/JHD-160221_ref172","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1054-3589(08)60921-7","article-title":"Coordinated expression of dopamine receptors in neostriatal medium spiny neurons","volume":"42","author":"Surmeier","year":"1998","journal-title":"Adv Pharmacol"},{"issue":"12","key":"10.3233\/JHD-160221_ref173","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1093\/cercor\/bhv209","article-title":"Dopamine D1 receptor-mediated transmission maintains information flow through the cortico-striato-entopeduncular direct pathway to release movements","volume":"25","author":"Chiken","year":"2015","journal-title":"Cereb Cortex"},{"issue":"5","key":"10.3233\/JHD-160221_ref174","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tins.2007.03.008","article-title":"D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons","volume":"30","author":"Surmeier","year":"2007","journal-title":"Trends Neurosci"},{"issue":"1-2","key":"10.3233\/JHD-160221_ref175","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0304-3940(90)90399-T","article-title":"Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat","volume":"116","author":"Floran","year":"1990","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.3233\/JHD-160221_ref176","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.neuropharm.2008.06.002","article-title":"6-OHDA-induced hemiparkinsonism and chronic L-DOPA treatment increase dopamine D1-stimulated [(3)H]-GABA release and [(3)H]-cAMP production in substantia nigra pars reticulata of the rat","volume":"55","author":"Rangel-Barajas","year":"2008","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.3233\/JHD-160221_ref177","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nbd.2010.08.018","article-title":"L-DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V\/VI and increased GABA release in the substantia nigra reticulata","volume":"41","author":"Rangel-Barajas","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"7","key":"10.3233\/JHD-160221_ref178","doi-asserted-by":"crossref","first-page":"R267","DOI":"10.1016\/j.cub.2016.02.036","article-title":"Direct and indirect dorsolateral striatum pathways reinforce different action strategies","volume":"26","author":"Vicente","year":"2016","journal-title":"Curr Biol"},{"issue":"1","key":"10.3233\/JHD-160221_ref179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(97)00784-2","article-title":"D2 receptor-mediated inhibition of GABA release by endogenous dopamine in the rat globus pallidus","volume":"237","author":"Floran","year":"1997","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.3233\/JHD-160221_ref180","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1124\/jpet.108.145425","article-title":"Cannabinoid agonists stimulate [3H]GABA release in the globus pallidus of the rat when G(i) protein-receptor coupling is restricted: Role of dopamine D2 receptors","volume":"328","author":"Gonzalez","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.3233\/JHD-160221_ref181","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0028-3908(01)00038-7","article-title":"Dopamine D2 receptor mediated presynaptic inhibition of striatopallidal GABA(A) IPSCs in vitro","volume":"41","author":"Cooper","year":"2001","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.3233\/JHD-160221_ref182","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.410420213","article-title":"Dopamine D1 and D2 receptor gene expression in the striatum in Huntington\u2019s disease","volume":"42","author":"Augood","year":"1997","journal-title":"Ann Neurol"},{"issue":"1","key":"10.3233\/JHD-160221_ref183","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(91)90448-3","article-title":"Heterogeneous dopamine receptor changes in early and late Huntington\u2019s disease","volume":"132","author":"Richfield","year":"1991","journal-title":"Neurosci Lett"},{"issue":"Pt 12","key":"10.3233\/JHD-160221_ref184","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/brain\/120.12.2207","article-title":"Cognitive deficits in Huntington\u2019s disease are predicted by dopaminergic PET markers and brain volumes","volume":"120","author":"Backman","year":"1997","journal-title":"Brain"},{"issue":"Pt 12","key":"10.3233\/JHD-160221_ref185","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","article-title":"Huntington\u2019s disease progression. PET and clinical observations","volume":"122","author":"Andrews","year":"1999","journal-title":"Brain"},{"issue":"1","key":"10.3233\/JHD-160221_ref186","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0306-4522(03)00595-5","article-title":"Delayed onset of Huntington\u2019s disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors","volume":"123","author":"Glass","year":"2004","journal-title":"Neuroscience"},{"issue":"11","key":"10.3233\/JHD-160221_ref187","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"6","key":"10.3233\/JHD-160221_ref188","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/jnr.10272","article-title":"Striatal neurochemical changes in transgenic models of Huntington\u2019s disease","volume":"68","author":"Ariano","year":"2002","journal-title":"J Neurosci Res"},{"issue":"10","key":"10.3233\/JHD-160221_ref189","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/dds037","article-title":"Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice","volume":"21","author":"Pouladi","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"1-2","key":"10.3233\/JHD-160221_ref190","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0169-328X(02)00216-4","article-title":"Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington\u2019s disease","volume":"102","author":"Spektor","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"10.3233\/JHD-160221_ref191","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/hmg\/ddu456","article-title":"Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington\u2019s disease","volume":"24","author":"Gratuze","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"14","key":"10.3233\/JHD-160221_ref192","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1523\/JNEUROSCI.18-14-05301.1998","article-title":"A complex program of striatal gene expression induced by dopaminergic stimulation","volume":"18","author":"Berke","year":"1998","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-160221_ref193","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fnbeh.2011.00071","article-title":"L-DOPA-induced dyskinesia and abnormal signaling in striatal medium spiny neurons: Focus on dopamine D1 receptor-mediated transmission","volume":"5","author":"Feyder","year":"2011","journal-title":"Front Behav Neurosci"},{"issue":"35","key":"10.3233\/JHD-160221_ref194","doi-asserted-by":"crossref","first-page":"11744","DOI":"10.1523\/JNEUROSCI.0864-14.2014","article-title":"Inhibition of adenylyl cyclase type 5 prevents L-DOPA-induced dyskinesia in an animal model of Parkinson\u2019s disease","volume":"34","author":"Park","year":"2014","journal-title":"J Neurosci"},{"issue":"5","key":"10.3233\/JHD-160221_ref195","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/archneurol.2012.54","article-title":"Autosomal dominant familial dyskinesia and facial myokymia: Single exome sequencing identifies a mutation in adenylyl cyclase 5","volume":"69","author":"Chen","year":"2012","journal-title":"Arch Neurol"},{"issue":"4","key":"10.3233\/JHD-160221_ref196","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1096\/fj.07-9814","article-title":"Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death","volume":"22","author":"Roze","year":"2008","journal-title":"FASEB J"},{"issue":"1","key":"10.3233\/JHD-160221_ref197","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nbd.2012.01.011","article-title":"Changes in the expression of extracellular regulated kinase (ERK 1\/2) in the R6\/2 mouse model of Huntington\u2019s disease after phosphodiesterase IV inhibition","volume":"46","author":"Fusco","year":"2012","journal-title":"Neurobiol Dis"},{"issue":"9","key":"10.3233\/JHD-160221_ref198","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1523\/JNEUROSCI.14-09-05623.1994","article-title":"Amphetamine regulates gene expression in rat striatum via transcription factor CREB","volume":"14","author":"Konradi","year":"1994","journal-title":"J Neurosci"},{"issue":"21","key":"10.3233\/JHD-160221_ref199","doi-asserted-by":"crossref","first-page":"8814","DOI":"10.1523\/JNEUROSCI.18-21-08814.1998","article-title":"Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation","volume":"18","author":"Sgambato","year":"1998","journal-title":"J Neurosci"},{"issue":"6","key":"10.3233\/JHD-160221_ref200","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/1073858403255839","article-title":"D1 dopamine receptor supersensitivity in the dopamine-depleted striatum animal model of Parkinson\u2019s disease","volume":"9","author":"Gerfen","year":"2003","journal-title":"Neuroscientist"},{"issue":"4","key":"10.3233\/JHD-160221_ref201","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","article-title":"Transcriptional signatures in Huntington\u2019s disease","volume":"83","author":"Cha","year":"2007","journal-title":"Prog Neurobiol"},{"issue":"3","key":"10.3233\/JHD-160221_ref202","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.neuroscience.2008.02.052","article-title":"Dopamine D1 receptor-mediated aggregation of N-terminal fragments of mutant huntingtin and cell death in a neuroblastoma cell line","volume":"153","author":"Robinson","year":"2008","journal-title":"Neuroscience"},{"issue":"4","key":"10.3233\/JHD-160221_ref203","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0306-4522(98)00400-X","article-title":"Forskolin and dopamine D1 receptor activation increase huntingtin\u2019s association with endosomes in immortalized neuronal cells of striatal origin","volume":"89","author":"Kim","year":"1999","journal-title":"Neuroscience"},{"issue":"4","key":"10.3233\/JHD-160221_ref204","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tips.2007.02.006","article-title":"The Akt-GSK-3 signaling cascade in the actions of dopamine","volume":"28","author":"Beaulieu","year":"2007","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.3233\/JHD-160221_ref205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1124\/mol.110.065409","article-title":"Signaling pathways leading to phosphorylation of Akt and GSK-3beta by activation of cloned human and rat cerebral D(2)and D(3) receptors","volume":"79","author":"Mannoury la Cour","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.3233\/JHD-160221_ref206","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnmol.2011.00038","article-title":"Beyond cAMP: The regulation of Akt and GSK3 by dopamine receptors","volume":"4","author":"Beaulieu","year":"2011","journal-title":"Front Mol Neurosci"},{"issue":"15","key":"10.3233\/JHD-160221_ref207","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1093\/hmg\/ddu119","article-title":"Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington\u2019s disease affected brain","volume":"23","author":"Lim","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"Pt 7","key":"10.3233\/JHD-160221_ref208","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","article-title":"GSK- Tricks of the trade for a multi-tasking kinase","volume":"116","author":"Doble","year":"2003","journal-title":"J Cell Sci"},{"issue":"22","key":"10.3233\/JHD-160221_ref209","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1093\/hmg\/ddu317","article-title":"Ubiquitin-specific protease-14 reduces cellular aggregates and protects against mutant huntingtin-induced cell degeneration: Involvement of the proteasome and ER stress-activated kinase IRE1alpha","volume":"23","author":"Hyrskyluoto","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"13","key":"10.3233\/JHD-160221_ref210","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1091\/mbc.E16-01-0026","article-title":"Ubiquilin\/Dsk2 promotes inclusion body formation and vacuole (lysosome)-mediated disposal of mutated huntingtin","volume":"27","author":"Chuang","year":"2016","journal-title":"Mol Biol Cell"},{"issue":"37","key":"10.3233\/JHD-160221_ref211","doi-asserted-by":"crossref","first-page":"33791-8(47)","DOI":"10.1074\/jbc.M204861200","article-title":"Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington\u2019s disease mutation","volume":"277","author":"Carmichael","year":"2002","journal-title":"J Biol Chem"},{"issue":"12","key":"10.3233\/JHD-160221_ref212","doi-asserted-by":"crossref","first-page":"e0144864","DOI":"10.1371\/journal.pone.0144864","article-title":"Huntingtin subcellular localisation is regulated by kinase signalling activity in the StHdhQ111 model of HD","volume":"10","author":"Bowles","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.3233\/JHD-160221_ref213","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1471-4159.2007.04586.x","article-title":"Dopamine depletion and subsequent treatment with L-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum","volume":"102","author":"Bychkov","year":"2007","journal-title":"J\u00a0Neurochem"},{"issue":"30","key":"10.3233\/JHD-160221_ref214","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1523\/JNEUROSCI.1396-07.2007","article-title":"Dopaminergic signaling and striatal neurodegeneration in Huntington\u2019s disease","volume":"27","author":"Tang","year":"2007","journal-title":"J Neurosci"},{"issue":"40","key":"10.3233\/JHD-160221_ref215","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1523\/JNEUROSCI.3237-08.2008","article-title":"Dopaminergic and glutamatergic signaling crosstalk in Huntington\u2019s disease neurodegeneration: The role of p25\/cyclin-dependent kinase 5","volume":"28","author":"Paoletti","year":"2008","journal-title":"J Neurosci"},{"issue":"3","key":"10.3233\/JHD-160221_ref216","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1755-5949.2010.00134.x","article-title":"Dopamine and glutamate in Huntington\u2019s disease: A balancing act","volume":"16","author":"Andre","year":"2010","journal-title":"CNS Neurosci Ther"},{"key":"10.3233\/JHD-160221_ref217","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fnsys.2011.00046","article-title":"Altered balance of activity in the striatal direct and indirect pathways in mouse models of Huntington\u2019s disease","volume":"5","author":"Andre","year":"2011","journal-title":"Front Syst Neurosci"},{"key":"10.3233\/JHD-160221_ref218","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fncel.2015.00025","article-title":"Modulation of the glutamatergic transmission by dopamine: A focus on Parkinson, Huntington and addiction diseases","volume":"9","author":"Gardoni","year":"2015","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.3233\/JHD-160221_ref219","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0006-8993(94)90263-1","article-title":"Tonic D2-mediated attenuation of cortical excitation in nucleus accumbens neurons recorded in vitro","volume":"634","author":"O\u2019Donnell","year":"1994","journal-title":"Brain Res"},{"issue":"18","key":"10.3233\/JHD-160221_ref220","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1523\/JNEUROSCI.16-18-05870.1996","article-title":"Modulatory actions of dopamine on NMDA receptor-mediated responses are reduced in D1A-deficient mutant mice","volume":"16","author":"Levine","year":"1996","journal-title":"J Neurosci"},{"issue":"9","key":"10.3233\/JHD-160221_ref221","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1523\/JNEUROSCI.17-09-03334.1997","article-title":"D1 receptor activation enhances evoked discharge in neostriatal medium spiny neurons by modulating an L-type Ca2+ conductance","volume":"17","author":"Hernandez-Lopez","year":"1997","journal-title":"J Neurosci"},{"issue":"24","key":"10.3233\/JHD-160221_ref222","doi-asserted-by":"crossref","first-page":"10297","DOI":"10.1523\/JNEUROSCI.18-24-10297.1998","article-title":"A dopamine\/D1 receptor\/protein kinase A\/dopamine- and cAMP-regulated phosphoprotein (Mr 32kDa)\/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor","volume":"18","author":"Snyder","year":"1998","journal-title":"J Neurosci"},{"issue":"2","key":"10.3233\/JHD-160221_ref223","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0026-895X(24)23206-5","article-title":"Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"57","author":"Dunah","year":"2000","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.3233\/JHD-160221_ref224","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0092-8674(02)00962-5","article-title":"Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor","volume":"111","author":"Lee","year":"2002","journal-title":"Cell"},{"issue":"22","key":"10.3233\/JHD-160221_ref225","doi-asserted-by":"crossref","first-page":"20196","DOI":"10.1074\/jbc.M213140200","article-title":"Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors","volume":"278","author":"Fiorentini","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"10.3233\/JHD-160221_ref226","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1124\/mol.65.1.121","article-title":"Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32","volume":"65","author":"Dunah","year":"2004","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.3233\/JHD-160221_ref227","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1471-4159.1999.0720634.x","article-title":"Inhibition of calcium-dependent NMDA receptor current rundown by calbindin-D28k","volume":"72","author":"Price","year":"1999","journal-title":"J Neurochem"},{"issue":"26","key":"10.3233\/JHD-160221_ref228","doi-asserted-by":"crossref","first-page":"14859","DOI":"10.1073\/pnas.94.26.14859","article-title":"The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses","volume":"94","author":"Blank","year":"1997","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"1","key":"10.3233\/JHD-160221_ref229","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/syn.890240102","article-title":"Neuromodulatory actions of dopamine on synaptically-evoked neostriatal responses in slices","volume":"24","author":"Levine","year":"1996","journal-title":"Synapse"},{"issue":"1","key":"10.3233\/JHD-160221_ref230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000017294","article-title":"Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum","volume":"20","author":"Cepeda","year":"1998","journal-title":"Dev Neurosci"},{"issue":"6","key":"10.3233\/JHD-160221_ref231","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1152\/jn.00361.2002","article-title":"Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: Role of D1 receptors and DARPP-32","volume":"88","author":"Flores-Hernandez","year":"2002","journal-title":"J Neurophysiol"},{"issue":"8","key":"10.3233\/JHD-160221_ref232","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nn.2592","article-title":"Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors","volume":"13","author":"Higley","year":"2010","journal-title":"Nat Neurosci"},{"issue":"5-6","key":"10.3233\/JHD-160221_ref233","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","article-title":"N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington\u2019s disease","volume":"81","author":"Fan","year":"2007","journal-title":"Prog Neurobiol"},{"issue":"6","key":"10.3233\/JHD-160221_ref234","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington\u2019s disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"issue":"3","key":"10.3233\/JHD-160221_ref235","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.mcn.2003.11.014","article-title":"Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington\u2019s disease","volume":"25","author":"Zeron","year":"2004","journal-title":"Mol Cell Neurosci"},{"key":"10.3233\/JHD-160221_ref236","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fnsys.2011.00028","article-title":"Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-d-aspartate currents by dopamine D1 receptor activation in striatum","volume":"5","author":"Jocoy","year":"2011","journal-title":"Front Syst Neurosci"},{"issue":"10","key":"10.3233\/JHD-160221_ref237","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1523\/JNEUROSCI.19-10-04180.1999","article-title":"The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro","volume":"19","author":"Tovar","year":"1999","journal-title":"J Neurosci"},{"issue":"1-2","key":"10.3233\/JHD-160221_ref238","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1570-9639(02)00455-7","article-title":"Coupling of extrasynaptic NMDA receptors to a CREB shut-off pathway is developmentally regulated","volume":"1600","author":"Hardingham","year":"2002","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.3233\/JHD-160221_ref239","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington\u2019s disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"key":"10.3233\/JHD-160221_ref240","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.nbd.2013.11.013","article-title":"Chronic blockade of extrasynaptic NMDA receptors ameliorates synaptic dysfunction and pro-death signaling in Huntington disease transgenic mice","volume":"62","author":"Dau","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"22","key":"10.3233\/JHD-160221_ref241","doi-asserted-by":"crossref","first-page":"18103","DOI":"10.1074\/jbc.M112.347427","article-title":"N-methyl-D-aspartate (NMDA) receptor composition modulates dendritic spine morphology in striatal medium spiny neurons","volume":"287","author":"Vastagh","year":"2012","journal-title":"J Biol Chem"},{"issue":"27","key":"10.3233\/JHD-160221_ref242","doi-asserted-by":"crossref","first-page":"24713","DOI":"10.1074\/jbc.M103501200","article-title":"Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95","volume":"276","author":"Sun","year":"2001","journal-title":"J Biol Chem"},{"issue":"35","key":"10.3233\/JHD-160221_ref243","doi-asserted-by":"crossref","first-page":"10928","DOI":"10.1523\/JNEUROSCI.2491-09.2009","article-title":"Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington\u2019s disease","volume":"29","author":"Fan","year":"2009","journal-title":"J Neurosci"},{"issue":"21","key":"10.3233\/JHD-160221_ref244","doi-asserted-by":"crossref","first-page":"15778","DOI":"10.1074\/jbc.M611485200","article-title":"Inhibition of the dopamine D1 receptor signaling by PSD-95","volume":"282","author":"Zhang","year":"2007","journal-title":"J Biol Chem"},{"issue":"7 Pt 2","key":"10.3233\/JHD-160221_ref245","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1523\/JNEUROSCI.15-07-05222.1995","article-title":"Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents","volume":"15","author":"Hersch","year":"1995","journal-title":"J Neurosci"},{"issue":"1-2","key":"10.3233\/JHD-160221_ref246","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/01677063.2014.892486","article-title":"Motor impairments, striatal degeneration, and altered dopamine-glutamate interplay in mice lacking PSD-95","volume":"28","author":"Zhang","year":"2014","journal-title":"J Neurogenet"},{"issue":"21","key":"10.3233\/JHD-160221_ref247","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1093\/hmg\/ddr351","article-title":"Increased PKA signaling disrupts recognition memory and spatial memory: Role in Huntington\u2019s disease","volume":"20","author":"Giralt","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"9-10","key":"10.3233\/JHD-160221_ref248","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/00001756-199707070-00019","article-title":"Dopamine facilitates striatal EPSPs through an L-type Ca2+ conductance","volume":"8","author":"Galarraga","year":"1997","journal-title":"Neuroreport"},{"issue":"1","key":"10.3233\/JHD-160221_ref249","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0896-6273(00)80358-X","article-title":"cAMP-dependent regulation of cardiac L-type Ca2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits","volume":"19","author":"Gao","year":"1997","journal-title":"Neuron"},{"key":"10.3233\/JHD-160221_ref250","first-page":"40","article-title":"Cholinergic and dopaminergic modulation of potassium conductances in neostriatal neurons","volume":"60","author":"Kitai","year":"1993","journal-title":"Adv Neurol"},{"issue":"2","key":"10.3233\/JHD-160221_ref251","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0896-6273(95)90294-5","article-title":"Modulation of calcium currents by a D1 dopaminergic protein kinase\/phosphatase cascade in rat neostriatal neurons","volume":"14","author":"Surmeier","year":"1995","journal-title":"Neuron"},{"issue":"3","key":"10.3233\/JHD-160221_ref252","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0306-4522(99)00493-5","article-title":"Ca2+ channels that activate Ca2+-dependent K+ currents in neostriatal neurons","volume":"95","author":"Vilchis","year":"2000","journal-title":"Neuroscience"},{"issue":"4","key":"10.3233\/JHD-160221_ref253","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0306-4522(92)90273-5","article-title":"Grafted neostriatal neurons express a late-developing transient potassium current","volume":"48","author":"Surmeier","year":"1992","journal-title":"Neuroscience"},{"issue":"7684","key":"10.3233\/JHD-160221_ref254","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0140-6736(70)90367-3","article-title":"Predictive test for Huntington\u2019s chorea","volume":"2","author":"Klawans","year":"1970","journal-title":"Lancet"},{"issue":"4","key":"10.3233\/JHD-160221_ref255","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J Neurol Sci"},{"issue":"18","key":"10.3233\/JHD-160221_ref256","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1097\/00001756-200512190-00010","article-title":"Transient striatal gamma local field potentials signal movement initiation in rats","volume":"16","author":"Masimore","year":"2005","journal-title":"Neuroreport"},{"issue":"17","key":"10.3233\/JHD-160221_ref257","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1523\/JNEUROSCI.5007-13.2014","article-title":"Corticostriatal coordination through coherent phase-amplitude coupling","volume":"34","author":"von Nicolai","year":"2014","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-160221_ref258","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nbd.2013.09.015","article-title":"Resolving pathobiological mechanisms relating to Huntington disease: Gait, balance, and involuntary movements in mice with targeted ablation of striatal D1 dopamine receptor cells","volume":"62","author":"Kim","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.3233\/JHD-160221_ref259","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2011.12.040","article-title":"Abnormal burst patterns of single neurons recorded in the substantia nigra reticulata of behaving 140 CAG Huntington\u2019s disease mice","volume":"512","author":"Murphy-Nakhnikian","year":"2012","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.3233\/JHD-160221_ref260","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1471-4159.1992.tb09283.x","article-title":"Increased cerebrospinal fluid dopamine and 3,4-dihydroxyphenylacetic acid levels in Huntington\u2019s disease: Evidence for an overactive dopaminergic brain transmission","volume":"58","author":"Garrett","year":"1992","journal-title":"J Neurochem"},{"issue":"9","key":"10.3233\/JHD-160221_ref261","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/NEN.0b013e3181ee005d","article-title":"Hyperdopaminergic status in experimental Huntington disease","volume":"69","author":"Jahanshahi","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JHD-160221_ref262","doi-asserted-by":"crossref","unstructured":"Izquierdo A , Brigman JL , Radke AK , Rudebeck PH , Holmes A . The neural basis of reversal learning: An updated perspective. Neuroscience. In Press 2016.","DOI":"10.1016\/j.neuroscience.2016.03.021"},{"issue":"1","key":"10.3233\/JHD-160221_ref263","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1162\/089892900561931","article-title":"Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans","volume":"12","author":"Rogers","year":"2000","journal-title":"J Cogn Neurosci"},{"issue":"11","key":"10.3233\/JHD-160221_ref264","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1523\/JNEUROSCI.22-11-04563.2002","article-title":"Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging","volume":"22","author":"Cools","year":"2002","journal-title":"J\u00a0Neurosci"},{"issue":"1","key":"10.3233\/JHD-160221_ref265","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbr.2010.02.017","article-title":"Selective lesions of the dorsomedial striatum impair serial spatial reversal learning in rats","volume":"210","author":"Casta\u00f1\u00e9","year":"2010","journal-title":"Behav Brain Res"},{"issue":"5","key":"10.3233\/JHD-160221_ref266","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/brain\/119.5.1633","article-title":"Executive and mnemonic functions in early Huntington\u2019s disease","volume":"119","author":"Lawrence","year":"1996","journal-title":"Brain"},{"issue":"13","key":"10.3233\/JHD-160221_ref267","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archneur.1983.04050120041005","article-title":"Development of neuropsychological deficits in Huntington\u2019s disease","volume":"40","author":"Josiassen","year":"1983","journal-title":"Arch Neurol"},{"issue":"7","key":"10.3233\/JHD-160221_ref268","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/brain\/121.7.1329","article-title":"Evidence for specific cognitive deficits in preclinical Huntington\u2019s disease","volume":"121","author":"Lawrence","year":"1998","journal-title":"Brain"},{"issue":"7","key":"10.3233\/JHD-160221_ref269","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/brain\/121.7.1343","article-title":"The relationship between striatal dopamine receptor binding and cognitive performance in Huntington\u2019s disease","volume":"121","author":"Lawrence","year":"1998","journal-title":"Brain"},{"issue":"4","key":"10.3233\/JHD-160221_ref270","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1176\/jnp.2008.20.4.466","article-title":"Neuropsychological deficits in Huntington\u2019s disease gene carriers and correlates of early \u201cconversion\u201d","volume":"20","author":"Brandt","year":"2008","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2-3","key":"10.3233\/JHD-160221_ref271","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainresbull.2006.10.017","article-title":"Depletion of Complexin II does not affect disease progression in a mouse model of Huntington\u2019s disease (HD); support for role for complexin II in behavioural pathology in a mouse model of HD","volume":"72","author":"Glynn","year":"2007","journal-title":"Brain Res Bull"},{"issue":"11","key":"10.3233\/JHD-160221_ref272","doi-asserted-by":"crossref","first-page":"e71633","DOI":"10.1371\/journal.pone.0071633","article-title":"Reversal learning and associative memory impairments in a BACHD rat model for Huntington disease","volume":"8","author":"Abada","year":"2013","journal-title":"PLoS One"},{"issue":"16","key":"10.3233\/JHD-160221_ref273","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington\u2019s disease","volume":"25","author":"Van Raamsdonk","year":"2005","journal-title":"J Neurosci"},{"issue":"2-3","key":"10.3233\/JHD-160221_ref274","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.brainresbull.2011.05.010","article-title":"Selective cognitive impairment in the YAC128 Huntington\u2019s disease mouse","volume":"88","author":"Brooks","year":"2012","journal-title":"Brain Res Bull"},{"issue":"2","key":"10.3233\/JHD-160221_ref275","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nbd.2011.04.009","article-title":"Reduced expression of conditioned fear in the R6\/2 mouse model of Huntington\u2019s disease is related to abnormal activity in prelimbic cortex","volume":"43","author":"Walker","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.3233\/JHD-160221_ref276","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0006-3223(92)90049-6","article-title":"Obsessive-compulsive disorder in Huntington\u2019s disease","volume":"31","author":"Cummings","year":"1992","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JHD-160221_ref277","unstructured":"Rangel-Barajas C , Bunner K , Barton SJ , Rebec GV . Striatal local field potential activity in the Q175 knock-in mouse model of Huntington\u2019s disease during plus maze motor activity. Soc Neurosci Abstr. 2015;No. 303.10."},{"key":"10.3233\/JHD-160221_ref278","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1741-7007-3-4","article-title":"Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: A model of obsessive compulsive disorder and Tourette\u2019s","volume":"3","author":"Berridge","year":"2005","journal-title":"BMC Biol"},{"issue":"3","key":"10.3233\/JHD-160221_ref279","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF00179191","article-title":"Dopamine agonist-induced stereotypic grooming and self-mutilation following striatal dopamine depletion","volume":"90","author":"Hartgraves","year":"1986","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.3233\/JHD-160221_ref280","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/1098-2396(20000901)37:3<205::AID-SYN4>3.0.CO;2-A","article-title":"Super-stereotypy II: Enhancement of a complex movement sequence by intraventricular dopamine D1 agonists","volume":"37","author":"Berridge","year":"2000","journal-title":"Synapse"},{"key":"10.3233\/JHD-160221_ref281","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2010.01.052","article-title":"Dopamine receptor modulation of repetitive grooming actions in the rat: Potential relevance for Tourette syndrome","volume":"1322","author":"Taylor","year":"2010","journal-title":"Brain Res"},{"issue":"7","key":"10.3233\/JHD-160221_ref282","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/cercor\/bhj043","article-title":"Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits","volume":"16","author":"Levy","year":"2006","journal-title":"Cereb Cortex"},{"issue":"8","key":"10.3233\/JHD-160221_ref283","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.neunet.2006.06.007","article-title":"Heterarchical reinforcement-learning model for integration of multiple cortico-striatal loops: fMRI examination in stimulus-action-reward association learning","volume":"19","author":"Haruno","year":"2006","journal-title":"Neural Netw"},{"key":"10.3233\/JHD-160221_ref284","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cortex.2015.11.004","article-title":"Fronto-striatal organization: Defining functional and microstructural substrates of behavioural flexibility","volume":"74","author":"Morris","year":"2016","journal-title":"Cortex"},{"issue":"3","key":"10.3233\/JHD-160221_ref285","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.neubiorev.2010.02.005","article-title":"The neurobiology of repetitive behavior: \u2026 And men","volume":"35","author":"Langen","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"10.3233\/JHD-160221_ref286","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neubiorev.2010.02.004","article-title":"The neurobiology of repetitive behavior: Of mice \u2026","volume":"35","author":"Langen","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"issue":"31","key":"10.3233\/JHD-160221_ref287","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1523\/JNEUROSCI.1554-07.2007","article-title":"The role of the dorsal striatum in reward and decision-making","volume":"27","author":"Balleine","year":"2007","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-160221_ref288","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.parkreldis.2016.04.017","article-title":"Resting-state fMRI reveals potential neural correlates of impaired cognition in Huntington\u2019s disease","volume":"27","author":"Liu","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JHD-160221_ref289","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nbd.2015.03.030","article-title":"Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington\u2019s disease models","volume":"79","author":"Li","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.3233\/JHD-160221_ref290","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ana.410400110","article-title":"Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington\u2019s disease","volume":"40","author":"Weeks","year":"1996","journal-title":"Ann Neurol"},{"issue":"19","key":"10.3233\/JHD-160221_ref291","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/hmg\/ddl224","article-title":"Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington\u2019s disease","volume":"15","author":"Cummings","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.3233\/JHD-160221_ref292","first-page":"219","article-title":"Behavioral changes in Huntington disease","volume":"14","author":"Craufurd","year":"2001","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"issue":"2","key":"10.3233\/JHD-160221_ref293","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.genhosppsych.2007.11.005","article-title":"Behavioural problems in Huntington\u2019s disease using the Problem Behaviours Assessment","volume":"30","author":"Kingma","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"issue":"5","key":"10.3233\/JHD-160221_ref294","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s11940-010-0088-3","article-title":"Treatment of Irritability in Huntington\u2019s disease","volume":"12","author":"van Duijn","year":"2010","journal-title":"Curr Treat Options Neurol"},{"issue":"7","key":"10.3233\/JHD-160221_ref295","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: Analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.3233\/JHD-160221_ref296","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1517\/14656566.2016.1109630","article-title":"Advancing pharmacotherapy for treating Huntington\u2019s disease: A review of the existing literature","volume":"17","author":"Mason","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"10.3233\/JHD-160221_ref297","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.parkreldis.2016.02.008","article-title":"Neuropsychiatric symptoms are very common in premanifest and early stage Huntington\u2019s Disease","volume":"25","author":"Martinez-Horta","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"10.3233\/JHD-160221_ref298","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2217\/nmt.11.45","article-title":"Depression in the early stages of Huntington disease","volume":"1","author":"Epping","year":"2011","journal-title":"Neurodegener Dis Manag"},{"issue":"1","key":"10.3233\/JHD-160221_ref299","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1176\/appi.neuropsych.11030057","article-title":"Longitudinal evaluation of neuropsychiatric symptoms in Huntington\u2019s disease","volume":"24","author":"Thompson","year":"2012","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"10.3233\/JHD-160221_ref300","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0033-3182(00)71170-4","article-title":"Neuropsychiatry of Huntington\u2019s disease and other basal ganglia disorders","volume":"41","author":"Rosenblatt","year":"2000","journal-title":"Psychosomatics"},{"issue":"4","key":"10.3233\/JHD-160221_ref301","first-page":"221","article-title":"Personality disorder in Huntington\u2019s disease","volume":"3","author":"Dewhurst","year":"1970","journal-title":"Psychiatr Clin (Basel)"},{"issue":"4","key":"10.3233\/JHD-160221_ref302","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/jnp.2007.19.4.441","article-title":"Psychopathology in verified Huntington\u2019s disease gene carriers","volume":"19","author":"van Duijn","year":"2007","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"10.3233\/JHD-160221_ref303","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000343210","article-title":"Course of irritability, depression and apathy in Huntington\u2019s disease in relation to motor symptoms during a two-year follow-up period","volume":"13","author":"van Duijn","year":"2014","journal-title":"Neurodegener Dis"},{"issue":"3","key":"10.3233\/JHD-160221_ref304","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijdevneu.2011.02.006","article-title":"Prefrontal cortical network connections: Key site of vulnerability in stress and schizophrenia","volume":"29","author":"Arnsten","year":"2011","journal-title":"Int J Dev Neurosci"},{"key":"10.3233\/JHD-160221_ref305","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0074-7742(06)78006-0","article-title":"Serotonin and dopamine interactions in rodents and primates: Implications for psychosis and antipsychotic drug development","volume":"78","author":"Marek","year":"2007","journal-title":"Int Rev Neurobiol"},{"issue":"8","key":"10.3233\/JHD-160221_ref306","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrn.2016.57","article-title":"Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression","volume":"17","author":"Grace","year":"2016","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"10.3233\/JHD-160221_ref307","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0193-953X(18)30215-6","article-title":"Neuroimaging studies of obsessive compulsive disorder","volume":"15","author":"Baxter","year":"1992","journal-title":"Psychiatr Clin North Am"},{"key":"10.3233\/JHD-160221_ref308","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1749-6632.1988.tb42117.x","article-title":"Mesocortical dopaminergic function and human cognition","volume":"537","author":"Weinberger","year":"1988","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.3233\/JHD-160221_ref309","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1152\/jn.1992.67.5.1325","article-title":"Presynaptic dopamine D1 receptors attenuate excitatory and inhibitory limbic inputs to the shell region of the rat nucleus accumbens studied in vitro","volume":"67","author":"Pennartz","year":"1992","journal-title":"J\u00a0Neurophysiol"},{"issue":"5","key":"10.3233\/JHD-160221_ref310","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1523\/JNEUROSCI.16-05-01591.1996","article-title":"Psychostimulants depress excitatory synaptic transmission in the nucleus accumbens via presynaptic D1-like dopamine receptors","volume":"16","author":"Nicola","year":"1996","journal-title":"J\u00a0Neurosci"},{"key":"10.3233\/JHD-160221_ref311","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.nicl.2015.02.018","article-title":"Functional connectivity modeling of consistent cortico-striatal degeneration in Huntington\u2019s disease","volume":"7","author":"Dogan","year":"2015","journal-title":"Neuroimage Clin"},{"issue":"2","key":"10.3233\/JHD-160221_ref312","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3233\/JHD-120039","article-title":"Antidepressant-like effect of the norepinephrine-dopamine reuptake inhibitor bupropion in a mouse model of Huntington\u2019s disease with dopaminergic dysfunction","volume":"1","author":"Renoir","year":"2012","journal-title":"J Huntingtons Dis"},{"issue":"9","key":"10.3233\/JHD-160221_ref313","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1017\/S003329171300247X","article-title":"The neuroanatomy of subthreshold depressive symptoms in Huntington\u2019s disease: A combined diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) study","volume":"44","author":"Sprengelmeyer","year":"2014","journal-title":"Psychol Med"},{"issue":"12","key":"10.3233\/JHD-160221_ref314","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2165\/11208330-000000000-00000","article-title":"Tetrabenazine: For chorea associated with Huntington\u2019s disease","volume":"25","author":"Scott","year":"2011","journal-title":"CNS Drugs"},{"issue":"11","key":"10.3233\/JHD-160221_ref315","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/0024-3205(76)90071-0","article-title":"Neurochemical changes following the administration of depleters of biogenic monoamines","volume":"19","author":"Lane","year":"1976","journal-title":"Life Sci"},{"issue":"7","key":"10.3233\/JHD-160221_ref316","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0028-3908(88)90080-9","article-title":"Depletion of monoamine transmitters by tetrabenazine in brain tissue in Huntington\u2019s disease","volume":"27","author":"Pearson","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.3233\/JHD-160221_ref317","doi-asserted-by":"crossref","first-page":"18-1326-5-18","DOI":"10.1186\/1750-1326-5-18","article-title":"Tetrabenazine is neuroprotective in Huntington\u2019s disease mice","volume":"5","author":"Wang","year":"2010","journal-title":"Mol Neurodegener"},{"issue":"3-4","key":"10.3233\/JHD-160221_ref318","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0014-2999(84)90562-4","article-title":"Tetrabenazine-induced depletion of brain monoamines: Characterization and interaction with selected antidepressants","volume":"102","author":"Pettibone","year":"1984","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.3233\/JHD-160221_ref319","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jps.2600760610","article-title":"Concentration-effect relationships of tetrabenazine and dihydrotetrabenazine in the rat","volume":"76","author":"Mehvar","year":"1987","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.3233\/JHD-160221_ref320","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.clinthera.2012.06.010","article-title":"Tetrabenazine for the treatment of hyperkinetic movement disorders: A review of the literature","volume":"34","author":"Chen","year":"2012","journal-title":"Clin Ther"},{"issue":"3","key":"10.3233\/JHD-160221_ref321","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/WNF.0b013e3180ca77ea","article-title":"A study of chorea after tetrabenazine withdrawal in patients with Huntington disease","volume":"31","author":"Frank","year":"2008","journal-title":"Clin Neuropharmacol"},{"issue":"5","key":"10.3233\/JHD-160221_ref322","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1021\/tx600325u","article-title":"Inhibition of VMAT-2 and DT-diaphorase induce cell death in a substantia nigra-derived cell line\u2013an experimental cell model for dopamine toxicity studies","volume":"20","author":"Fuentes","year":"2007","journal-title":"Chem Res Toxicol"},{"issue":"2","key":"10.3233\/JHD-160221_ref323","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/mds.25278","article-title":"Analysis of CYP2D6 genotype and response to tetrabenazine","volume":"28","author":"Mehanna","year":"2013","journal-title":"Mov Disord"},{"issue":"8","key":"10.3233\/JHD-160221_ref324","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/cns.12425","article-title":"A new VMAT-2 inhibitor NBI-49 in the treatment of Huntington disease","volume":"21","author":"Chen","year":"2015","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"10.3233\/JHD-160221_ref325","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0026-895X(25)08945-X","article-title":"In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone","volume":"41","author":"Leysen","year":"1992","journal-title":"Mol Pharmacol"},{"issue":"Suppl","key":"10.3233\/JHD-160221_ref326","first-page":"5","article-title":"Risperidone: A novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity","volume":"55","author":"Leysen","year":"1994","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.3233\/JHD-160221_ref327","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-3565(24)37395-1","article-title":"Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5\u2019\u2013gamma-thio-triphosphate\u201335S- binding","volume":"285","author":"Malmberg","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.3233\/JHD-160221_ref328","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/00048677509159834","article-title":"A double blind trial of lithium carbonate and haloperidol in Huntington\u2019s chorea","volume":"9","author":"Leonard","year":"1975","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"10.3233\/JHD-160221_ref329","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.38.1.84","article-title":"Serum haloperidol concentration and choreiform movements in Huntington\u2019s disease","volume":"38","author":"Barr","year":"1988","journal-title":"Neurology"},{"issue":"8","key":"10.3233\/JHD-160221_ref330","first-page":"282","article-title":"Huntington disease: Tetrabenazine compared to haloperidol in the reduction of involuntary movements","volume":"4","author":"Gimenez-Roldan","year":"1989","journal-title":"Neurologia"},{"issue":"4","key":"10.3233\/JHD-160221_ref331","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/j.1552-4604.1984.tb01831.x","article-title":"Comparison of haloperidol and chlorpromazine in the treatment of phencyclidine psychosis","volume":"24","author":"Giannini","year":"1984","journal-title":"J Clin Pharmacol"},{"issue":"2-3","key":"10.3233\/JHD-160221_ref332","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/15563658508990627","article-title":"Treatment of phenylcyclohexylpyrrolidine (PHP) psychosis with haloperidol","volume":"23","author":"Giannini","year":"1985","journal-title":"J Toxicol Clin Toxicol"},{"issue":"5 Suppl","key":"10.3233\/JHD-160221_ref333","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0269881111424929","article-title":"Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: A systematic review of head-head comparisons","volume":"26","author":"Haddad","year":"2012","journal-title":"J Psychopharmacol"},{"issue":"8","key":"10.3233\/JHD-160221_ref334","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/jnnp.47.8.844","article-title":"A double blind trial of sulpiride in Huntington\u2019s disease and tardive dyskinesia","volume":"47","author":"Quinn","year":"1984","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JHD-160221_ref335","first-page":"573","article-title":"Huntington\u2019s disease: Clinical effects of a short-term treatment with pimozide","volume":"24","author":"Arena","year":"1980","journal-title":"Adv Biochem Psychopharmacol"},{"issue":"5","key":"10.3233\/JHD-160221_ref336","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1111\/j.1471-4159.1986.tb01785.x","article-title":"3H]Fluphenazine binding to brain membranes: Simultaneous measurement of D-1 and D-2 receptor sites","volume":"46","author":"Morgan","year":"1986","journal-title":"J Neurochem"},{"issue":"2","key":"10.3233\/JHD-160221_ref337","first-page":"177","article-title":"Fluphenazine decanoate in the treatment of chorea: A double-blind study","volume":"20","author":"Terrence","year":"1976","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.3233\/JHD-160221_ref338","first-page":"47","article-title":"An overview of the mechanism of action of clozapine","volume":"55","author":"Meltzer","year":"1994","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.3233\/JHD-160221_ref339","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1212\/WNL.44.5.821","article-title":"Clozapine in Huntington\u2019s chorea","volume":"44","author":"Bonuccelli","year":"1994","journal-title":"Neurology"},{"issue":"1","key":"10.3233\/JHD-160221_ref340","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/jnnp.63.1.35","article-title":"Clozapine versus placebo in Huntington\u2019s disease: A double blind randomised comparative study","volume":"63","author":"van Vugt","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.3233\/JHD-160221_ref341","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1176\/appi.ajp.160.8.1396","article-title":"Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of olanzapine versus haloperidol","volume":"160","author":"Lieberman","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.3233\/JHD-160221_ref342","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/mds.22188","article-title":"A Europe-wide assessment of current medication choices in Huntington\u2019s disease","volume":"23","author":"Priller","year":"2008","journal-title":"Mov Disord"},{"issue":"3-4","key":"10.3233\/JHD-160221_ref343","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0361-9230(01)00648-7","article-title":"Onset and pre-onset studies to define the Huntington\u2019s disease natural history","volume":"56","author":"Squitieri","year":"2001","journal-title":"Brain Res Bull"},{"issue":"6","key":"10.3233\/JHD-160221_ref344","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1034\/j.1600-0404.2002.01197.x","article-title":"Olanzapine in Huntington\u2019s disease","volume":"105","author":"Paleacu","year":"2002","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"10.3233\/JHD-160221_ref345","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00004850-200203000-00009","article-title":"High-dose olanzapine in Huntington\u2019s disease","volume":"17","author":"Bonelli","year":"2002","journal-title":"Int Clin Psychopharmacol"},{"key":"10.3233\/JHD-160221_ref346","doi-asserted-by":"crossref","unstructured":"Nguyen CT , Rosen JA , Bota RG . Aripiprazole partial agonism at 5-HT2C: A comparison of weight gain associated with aripiprazole adjunctive to antidepressants with high versus low serotonergic activities. Prim Care Companion CNS Disord. 2012;14(5): doi: 10.4088\/PCC.12m01386","DOI":"10.4088\/PCC.12m01386"},{"issue":"4","key":"10.3233\/JHD-160221_ref347","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1527-3458.2004.tb00030.x","article-title":"Aripiprazole: A novel atypical antipsychotic drug with a uniquely robust pharmacology","volume":"10","author":"Davies","year":"2004","journal-title":"CNS Drug Rev"},{"issue":"1","key":"10.3233\/JHD-160221_ref348","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/mds.22376","article-title":"Treatment of the symptoms of Huntington\u2019s disease: Preliminary results comparing aripiprazole and tetrabenazine","volume":"24","author":"Brusa","year":"2009","journal-title":"Mov Disord"},{"key":"10.3233\/JHD-160221_ref349","first-page":"1","article-title":"Aripiprazole in the treatment of Huntington\u2019s disease: A case series","volume":"5","author":"Ciammola","year":"2009","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"3","key":"10.3233\/JHD-160221_ref350","first-page":"155","article-title":"Effects of DA agonist in Huntington disease hyperkinesia","volume":"1","author":"Caraceni","year":"1980","journal-title":"Ital J Neurol Sci"},{"issue":"10","key":"10.3233\/JHD-160221_ref351","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/jnnp.39.10.958","article-title":"Levodopa and Huntington\u2019s chorea","volume":"39","author":"Loeb","year":"1976","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.3233\/JHD-160221_ref352","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/jnnp.68.2.238","article-title":"Late onset levodopa responsive Huntington\u2019s disease with minimal chorea masquerading as Parkinson plus syndrome","volume":"68","author":"Reuter","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.3233\/JHD-160221_ref353","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1517\/14728210902918299","article-title":"Emerging drug therapies in Huntington\u2019s disease","volume":"14","author":"Mason","year":"2009","journal-title":"Expert Opin Emerg Drugs"},{"issue":"1","key":"10.3233\/JHD-160221_ref354","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1152\/jn.00502.2012","article-title":"Mathematical model of dopamine autoreceptors and uptake inhibitors and their influence on tonic and phasic dopamine signaling","volume":"109","author":"Dreyer","year":"2013","journal-title":"J Neurophysiol"},{"issue":"4","key":"10.3233\/JHD-160221_ref355","first-page":"602","article-title":"Dopamine receptor pharmacology","volume":"6","author":"Seeman","year":"1993","journal-title":"Curr Opin Neurol Neurosurg"},{"issue":"6","key":"10.3233\/JHD-160221_ref356","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1021\/jm901689v","article-title":"Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16)","volume":"53","author":"Pettersson","year":"2010","journal-title":"J Med Chem"},{"issue":"26","key":"10.3233\/JHD-160221_ref357","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.2174\/1381612821666150724100830","article-title":"Bitropic D3 dopamine receptor selective compounds as potential antipsychotics","volume":"21","author":"Luedtke","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.3233\/JHD-160221_ref358","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neuropharm.2014.10.030","article-title":"Pharmacological modulation of abnormal involuntary DOI-induced head twitch response movements in male DBA\/2J mice: II. Effects of D3 dopamine receptor selective compounds","volume":"93","author":"Rangel-Barajas","year":"2015","journal-title":"Neuropharmacology"},{"issue":"1-3","key":"10.3233\/JHD-160221_ref359","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejphar.2010.07.023","article-title":"In vivo pharmacology of the dopaminergic stabilizer pridopidine","volume":"644","author":"Ponten","year":"2010","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"10.3233\/JHD-160221_ref360","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1212\/WNL.0b013e3182886965","article-title":"One-year safety and tolerability profile of pridopidine in patients with Huntington disease","volume":"80","author":"Squitieri","year":"2013","journal-title":"Neurology"},{"issue":"12","key":"10.3233\/JHD-160221_ref361","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1474-4422(11)70233-2","article-title":"Pridopidine for the treatment of motor function in patients with Huntington\u2019s disease (MermaiHD): A phase 3, randomised, double-blind, placebo-controlled trial","volume":"10","author":"de Yebenes","year":"2011","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.3233\/JHD-160221_ref362","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.2147\/DDDT.S65738","article-title":"Profile of pridopidine and its potential in the treatment of Huntington disease: The evidence to date","volume":"28","author":"Squitieri","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.3233\/JHD-160221_ref363","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brainres.2011.12.047","article-title":"Neuroprotective effects of high affinity Sigma1 receptor selective compounds","volume":"1441","author":"Luedtke","year":"2012","journal-title":"Brain Res"},{"issue":"Pt 7","key":"10.3233\/JHD-160221_ref364","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/brain\/awu107","article-title":"Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism","volume":"137","author":"Francardo","year":"2014","journal-title":"Brain"},{"key":"10.3233\/JHD-160221_ref365","doi-asserted-by":"crossref","first-page":"e1832","DOI":"10.1038\/cddis.2015.194","article-title":"Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons","volume":"6","author":"Hong","year":"2015","journal-title":"Cell Death Dis"},{"issue":"10","key":"10.3233\/JHD-160221_ref366","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1111\/bph.13076","article-title":"The effects of sigma (sigma1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice","volume":"172","author":"Malik","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.3233\/JHD-160221_ref367","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pbb.2016.07.001","article-title":"The effect of the sigma-1 receptor selective compound LS-1-137 on the DOI-induced head twitch response in mice","volume":"148","author":"Malik","year":"2016","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-160221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:57:13Z","timestamp":1777453033000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-160221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,15]]},"references-count":367,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jhd-160221","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,15]]}}}